AVTX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (11 Jun 2024 @ 14:10):
Our systems believe the stock currently is undervalued by 50 054 374.01% compare to its pairs and should correct upwards.

Stats
Today's Volume	5 380
Average Volume	674 911
Market Cap	11.49M
EPS	$-141.14 ( Q1 \| 2024-05-13 )
Next earnings date	( $-0.190 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.220 (Sector) 42.63 (Industry) 24.32
ATR14	$0.133 (1.20%)

AADI -0.57%

ABCL -3.85%

ABCM 0.04%

ABEO 0.22%

ABIO 1.57%

ABOS 3.24%

ABSI -1.33%

ABUS 0.96%

ABVX -1.26%

ACAD 0.24%

ACER -17.95%

ACET -0.76%

ACGN 1.29%

ACHL -0.29%

ACHV -1.12%

ACIU 0.22%

ACLX 0.49%

ACRV 2.12%

ACST -1.55%

ACXP 3.75%

ADAG 3.52%

ADAP -0.48%

ADGI 0.87%

ADIL 2.28%

ADMA 0.14%

ADPT -1.72%

ADTX -1.51%

ADVM -2.47%

ADXN -4.46%

AEON 1.33%

AEZS -5.62%

AFMD 6.05%

AGEN -2.68%

AGIO 0.49%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW 50.66%

AKBA 1.83%

AKRO 0.70%

AKTX 22.74%

AKUS 0.00%

ALBO 0.00%

ALDX -1.81%

ALEC -0.78%

ALGS -3.46%

ALKS 1.74%

ALLK -4.20%

ALLO 2.66%

ALLR -8.00%

ALNA 3.16%

ALNY 1.87%

ALPN 0.00%

ALPX 0.00%

ALRN -0.91%

ALT 0.89%

ALVR -0.11%

ALXN 0.00%

ALXO -0.92%

ALZN -2.01%

AMRN 19.11%

AMTI -3.13%

ANAB -0.32%

ANEB 4.35%

ANGN 0.00%

ANIX -0.56%

ANL 3.29%

ANNX -5.59%

ANPC -3.15%

APGE -1.18%

APGN 8.48%

APGNW 30.65%

APLM 0.00%

APLS 2.11%

APLT 0.10%

APM -2.56%

APOP 0.38%

APRE -2.23%

APTO 0.56%

APTX 3.17%

APVO -3.01%

ARAV -13.39%

ARCT 1.87%

ARDS -17.00%

ARDX 3.25%

ARGX -0.42%

ARNA 0.00%

ARPO -0.90%

ARQT 3.11%

ARTL 1.85%

ARTLW 0.00%

ARVN -2.00%

ARWR 0.49%

ASLN -0.21%

ASMB 5.42%

ASND 2.09%

ATAI -3.21%

ATHA 0.00%

ATHE 0.52%

ATHX -33.50%

ATNF -3.80%

ATOS 1.67%

ATRA 6.51%

ATXI -1.43%

ATXS 0.71%

AUPH 2.18%

AURA -0.62%

AUTL 2.04%

AVBP 0.70%

AVEO 0.00%

AVIR 1.58%

AVRO -1.26%

AVTE -0.30%

AVTX 1.78%

AVXL -2.51%

AXLA 0.00%

AXSM -5.07%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO -0.59%

BCAB 12.37%

BCDA 7.35%

BCDAW 73.91%

BCEL 2.41%

BCLI 1.22%

BCRX -1.46%

BCTX -4.25%

BCTXW -8.36%

BCYC 1.17%

BDRX -2.82%

BDTX 18.64%

BEAM 2.54%

BFRA -2.91%

BGNE 0.08%

BIOR -1.11%

BIVI 1.01%

BLCM -6.68%

BLI -5.88%

BLPH 8.33%

BLRX -1.56%

BLTE -0.51%

BLU 0.03%

BLUE 3.16%

BMEA 6.03%

BMRN 1.44%

BNOX -0.36%

BNTC 2.29%

BNTX 0.79%

BOLD -2.34%

BOLT 0.61%

BPMC 0.76%

BPTH 0.43%

BPTS -13.47%

BRNS -3.41%

BRTX -5.98%

BTAI -3.82%

BTTX -5.56%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.07%

CABA 0.55%

CADL 6.97%

CALA 0.00%

CALC 1.54%

CALT -0.74%

CAPR 4.25%

CARA -2.58%

CARM -6.39%

CASI 4.13%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -2.13%

CCCC 1.24%

CCXI 0.00%

CDAK 0.00%

CDIO -6.22%

CDIOW 5.49%

CDMO -0.50%

CDMOP 0.04%

CDT -2.92%

CDTTW 74.85%

CDTX -0.56%

CDXC 0.00%

CDXS -0.46%

CELC 2.25%

CELU 1.40%

CELUW -16.67%

CERC -1.68%

CERE -0.36%

CERO -3.99%

CEROW -2.44%

CFRX -27.95%

CGEM 1.78%

CGEN 0.00%

CGON 1.11%

CGTX 4.55%

CHMA -6.00%

CHRS -0.57%

CINC 0.00%

CING 0.40%

CINGW -44.50%

CKPT 2.06%

CLBS -16.75%

CLDX 1.82%

CLGN -0.76%

CLLS -2.74%

CLNN -3.98%

CLNNW 40.00%

CLRB 0.00%

CLSD 1.67%

CLSN -0.68%

CLVS 0.00%

CMMB -0.96%

CMND 2.95%

CMPI 0.00%

CMPX 0.83%

CMRA 8.70%

CMRAW 0.00%

CMRX -2.04%

CNCE 0.00%

CNSP -12.60%

CNST 0.00%

CNTA 3.08%

CNTB -1.30%

CNTX 8.03%

COCP 3.20%

COEPW 0.50%

COGT 0.81%

CORT 3.85%

COYA 14.10%

CPRX -0.70%

CRBP 10.99%

CRBU 2.13%

CRDF 1.36%

CRGX 0.70%

CRIS 0.50%

CRNX -0.07%

CRSP 4.43%

CRTX 2.63%

CRVO 1.68%

CRVS 3.33%

CSBR 2.58%

CTCX -2.00%

CTIC 0.06%

CTMX -7.95%

CTNM -4.58%

CTXR 5.05%

CUE -1.38%

CVAC -7.08%

CVKD 4.78%

CWBR -2.52%

CYAD -12.96%

CYCC -1.33%

CYCCP -3.75%

CYCN -0.87%

CYT -2.27%

CYTK -0.60%

CYTO -1.84%

DARE -2.21%

DAWN 1.04%

DBTX -0.81%

DBVT -3.37%

DFFN 10.28%

DICE 0.06%

DMAC -1.92%

DNLI 2.40%

DNTH 11.39%

DOMH 0.48%

DRMA 3.41%

DRMAW -12.50%

DRNA 0.00%

DRTS -1.27%

DRTSW 4.17%

DRUG -2.45%

DSGN 5.26%

DTIL -1.23%

DYAI 2.67%

EARS -1.77%

EDIT 0.94%

EDSA 2.25%

EFTR 1.54%

EFTRW -48.48%

EIGR 0.00%

ELAB -0.40%

ELDN 0.70%

ELEV -4.79%

ELOX -6.84%

ELTX -1.50%

ELVN -0.49%

ELYM -2.89%

ENGN 5.56%

ENGNW 19.70%

ENLV 0.36%

ENOB 1.79%

ENSC -3.59%

ENTA 3.21%

ENTO -4.17%

ENTX -3.36%

ENVB 0.26%

EPIX -0.37%

EPRX -0.74%

EPZM 0.00%

EQ 1.78%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.31%

ERNA 1.05%

ERYP 1.30%

ESLA 1.42%

ESLAW 12.98%

ETNB 0.47%

ETON 0.28%

ETTX 0.00%

EVAX -0.53%

EVGN -3.59%

EVLO 0.00%

EWTX -0.82%

EXAI 2.75%

EXEL -0.61%

EYEG -0.18%

EYEN 0.12%

EYPT 0.11%

FATE 2.20%

FBIO -2.03%

FBIOP -0.85%

FBLG -7.23%

FBRX 7.27%

FDMT 4.39%

FENC 0.99%

FGEN -0.44%

FHTX 0.17%

FIXX 0.77%

FMTX 0.00%

FNCH 3.70%

FOLD 1.26%

FREQ 4.76%

FRLN 0.15%

FRTX 5.26%

FSTX 0.00%

FTRE 0.31%

FULC -5.58%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -2.95%

GANX 7.18%

GBIO 6.19%

GBT 0.01%

GDTC 3.50%

GERN 3.77%

GHRS -0.08%

GLMD -1.71%

GLPG -1.21%

GLSI -3.58%

GLTO -1.89%

GLUE 6.84%

GLYC 3.13%

GMAB -2.22%

GMDA 0.00%

GMTX 0.00%

GNCA -85.71%

GNFT -7.89%

GNLX 0.21%

GNPX 5.76%

GNTA -4.20%

GOSS -0.70%

GOVX -0.63%

GOVXW 5.06%

GPCR -9.26%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 6.28%

GRTX 1.02%

GTHX -1.71%

GUTS -9.08%

GXGXW 41.67%

GYRE -3.40%

HALO -1.99%

HARP 0.09%

HCWB 5.60%

HEPA 6.36%

HGEN -84.62%

HILS 5.66%

HLVX 2.64%

HOOK 0.90%

HOTH -6.71%

HOWL -4.27%

HRMY -1.74%

HRTX -0.54%

HSTO 0.00%

HUMA -2.29%

HUMAW -14.83%

IBRX -1.92%

ICCC 1.40%

ICPT 0.21%

ICU -4.28%

ICUCW 24.73%

ICVX -0.91%

IDRA -23.04%

IDYA -2.69%

IFRX -2.53%

IGMS 2.20%

IKNA 0.28%

IKT 4.46%

IMAB 0.54%

IMCR 0.35%

IMGN 0.02%

IMGO 0.00%

IMMP 0.57%

IMMX -0.48%

IMNM -1.99%

IMNN -1.85%

IMPL -27.27%

IMRA 15.96%

IMRN 1.35%

IMRX 14.77%

IMTX 3.65%

IMTXW 4.52%

IMUX 2.44%

IMV 0.00%

IMVT -1.53%

INAB 6.11%

INBX -0.12%

INCY -0.22%

INDP -1.23%

INFI -52.38%

INKT 2.45%

INM 0.20%

INMB -0.46%

INO -0.31%

INSM 3.67%

INTS 2.20%

INVA -0.38%

INZY -0.63%

IOBT -0.40%

IONS 0.93%

IOVA 6.95%

IPA -2.88%

IPHA -3.85%

IPSC -2.39%

IRON -0.09%

ISEE 0.38%

ITOS -1.51%

ITRM -9.09%

IVA 0.16%

IVVD -1.49%

JAGX -9.14%

JANX -2.44%

JAZZ 1.17%

JNCE 0.00%

JSPR -0.33%

JSPRW 0.00%

JUNS 0.00%

JUNSW 0%

KA -2.17%

KALV 0.75%

KDNY 0.22%

KMPH -0.34%

KNSA -1.66%

KNTE -0.38%

KOD 2.88%

KPRX 0.99%

KPTI 2.40%

KRBP 2.55%

KRON 15.67%

KROS -1.68%

KRRO -6.07%

KRTX 0.03%

KRYS 0.34%

KTRA -6.49%

KTTA 8.93%

KTTAW 0.00%

KURA 2.08%

KYMR 0.93%

KYTX -2.39%

KZIA -1.12%

KZR -2.35%

LABP 0.57%

LBPH 2.37%

LBPS 0.00%

LBPSW 14.81%

LEGN -1.57%

LENZ 7.61%

LEXX -1.22%

LEXXW -6.54%

LGND -0.38%

LGNDV 0.00%

LGVN -6.59%

LIAN 0.00%

LIFE 2.70%

LIPO 3.94%

LIXT -0.41%

LIXTW 16.95%

LJPC -0.32%

LMNL 0.12%

LOGC -1.27%

LPCN -2.38%

LPTX -1.31%

LQDA -1.08%

LRMR -0.94%

LSTA 4.64%

LTRN 2.41%

LUMO 8.07%

LVTX 3.14%

LXEO -4.67%

LXRX 0.79%

LYEL 5.30%

LYRA -1.22%

MACK 0.00%

MBIO 12.98%

MBRX 6.46%

MCRB 11.68%

MDGL 11.56%

MDNA -13.16%

MDWD -1.76%

MDXG -0.43%

MEIP -1.75%

MESO 0.70%

MGNX 9.39%

MGTA -7.74%

MGTX -0.63%

MGX -0.08%

MIRM 2.78%

MIRO 0.59%

MIST -2.74%

MITO 0.00%

MLEC -0.84%

MLECW 0.00%

MLND -5.36%

MLTX 4.56%

MLYS -4.81%

MNKD 2.23%

MNMD -2.93%

MNOV -0.75%

MNPR 7.90%

MOLN 17.69%

MOR -1.16%

MORF -0.58%

MREO 2.59%

MRKR 10.96%

MRNA -0.21%

MRNS -2.60%

MRSN 2.03%

MRTX -0.17%

MRUS 6.68%

MRVI -2.19%

MTCR -1.29%

MTEM -3.45%

MTP -18.50%

MURA -0.74%

MYMD -0.49%

NAMS 0.56%

NAMSW 17.06%

NAUT -0.57%

NBRV 0.71%

NBSE -1.56%

NBTX -0.18%

NCNA -2.77%

NERV 0.31%

NEXI 3.30%

NGM -1.28%

NGNE -1.71%

NKGN -2.10%

NKGNW -6.98%

NKTR 3.99%

NKTX -0.61%

NLSP 6.24%

NLSPW -41.80%

NMRA -4.13%

NMTR -42.97%

NOVN -24.84%

NRBO 2.69%

NRIX 5.22%

NRSN -2.86%

NRSNW 23.47%

NRXP 2.52%

NRXPW -16.08%

NRXS -2.05%

NTBL 4.90%

NTEC -12.45%

NTHI 0%

NTLA 1.33%

NTRBW -45.05%

NUVL 0.61%

NVAX 4.81%

NVCT 2.94%

NVIV -34.28%

NXTC 2.92%

NYMX -0.05%

OABI -2.17%

OABIW 5.59%

OBIO 0.00%

OBSV 0.00%

OCEA -3.14%

OCGN -2.58%

OCS 0.76%

OCUL 1.51%

OCUP 0.88%

ODT -4.27%

OKYO 5.88%

OLMA -0.22%

OMER -2.34%

OMGA 0.94%

ONCO -2.45%

ONCR -3.08%

ONCS 31.87%

ONCT 4.51%

ONCY -0.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -3.10%

ORGS 6.04%

ORIC -4.65%

ORMP -2.82%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK 5.95%

OVID -0.97%

OYST 0.00%

PALI -2.60%

PASG 0.92%

PBLA 6.67%

PBM -1.40%

PBYI 0.00%

PCSA 3.77%

PCVX 0.56%

PDSB -1.77%

PEPG 1.12%

PGEN -1.47%

PHAR 6.80%

PHAS 0.00%

PHAT -0.23%

PHIO 0.75%

PHIOW 36.47%

PHVS 1.94%

PHXM -5.20%

PIRS 1.00%

PKBO 0.00%

PKBOW 0.00%

PLRX -3.65%

PLUR 2.27%

PMN -4.47%

PMVP 0.29%

PNT 0.16%

PPBT 10.33%

PRAX -2.00%

PRDS 0.93%

PRLD -0.25%

PROG -3.47%

PROK -25.66%

PRQR 1.10%

PRTA -4.28%

PRTC 4.56%

PRTG 2.83%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -4.52%

PSTX 4.34%

PTCT 0.23%

PTE -0.82%

PTGX 1.37%

PTIXW 143.75%

PULM -1.28%

PXMD 0.00%

PYPD 2.11%

PYXS 0.25%

QLGN 2.01%

QNCX 3.89%

QNRX -7.13%

QSI 1.16%

QSIAW 0.94%

QTTB -4.24%

QURE -2.88%

RAIN -1.63%

RANI -0.24%

RAPT -2.36%

RARE -0.61%

RCKT 1.75%

REGN 1.15%

RENB -4.72%

REPL -1.06%

RETA 0.02%

REUN -0.89%

REVB 2.71%

REVBU 3.46%

REVBW 79.69%

RGLS -2.24%

RGNX -1.24%

RIGL -1.96%

RLAY -5.05%

RLMD -2.88%

RLYB 2.95%

RNA 7.76%

RNAC -5.68%

RNAZ 6.20%

RNXT 4.90%

ROIV 0.14%

ROIVW 4.56%

RPHM -0.89%

RPRX 0.18%

RPTX -2.25%

RUBY 2.70%

RVLP -32.05%

RVMD -1.86%

RVMDW 76.53%

RVNC 5.47%

RVPH 0.00%

RVPHW 64.71%

RXDX 0.09%

RXRX -0.41%

RYTM 0.41%

RYZB 0.02%

RZLT -3.68%

SABS 0.90%

SABSW 89.00%

SAGE -3.76%

SANA -0.58%

SAVA 0.11%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -3.47%

SCPH 2.91%

SCPS 0.00%

SEEL -3.85%

SEER -1.38%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 5.30%

SGMT -0.61%

SGTX -2.56%

SIOX 22.63%

SLDB -4.22%

SLGL 6.44%

SLN -0.38%

SLNO 1.62%

SLRX 1.57%

SLS 1.06%

SMMT -2.94%

SNDX -0.58%

SNGX -2.92%

SNPX -1.68%

SONN -6.80%

SPPI -0.49%

SPRB -3.11%

SPRC -0.53%

SPRO 0.70%

SRNE -22.03%

SRPT -1.93%

SRRA 0.00%

SRRK 0.05%

SRZN -0.89%

STAB 0.00%

STOK 5.44%

STRO 0.26%

STSA 0.00%

STTK -0.75%

SURF -0.93%

SVRA -1.08%

SWTX -0.55%

SYBX 0.14%

SYRS 2.34%

TALS -0.73%

TARA 0.00%

TARS 2.47%

TBPH 0.11%

TCBP -0.94%

TCDA 0.00%

TCON -1.83%

TCRR 0.00%

TCRT -1.92%

TCRX -2.18%

TECH -0.04%

TENX -2.22%

TERN 2.86%

TFFP 2.70%

TGTX 1.13%

THRX 0.12%

TIL 2.77%

TLC 0.00%

TLSA -6.13%

TNGX -2.37%

TNXP -7.69%

TNYA -0.80%

TPST -3.63%

TRDA -0.22%

TRVI 2.57%

TRVN 0.93%

TSHA -3.70%

TSVT 0.00%

TTNP 7.60%

TVTX -0.55%

TYRA 0.80%

UBX -0.31%

UNCY 4.76%

URGN 1.80%

UTHR 0.80%

VACC 11.36%

VALN 3.34%

VAXX 8.58%

VBIV 1.71%

VBLT -8.77%

VCEL -1.13%

VCNX 0.79%

VCYT 1.34%

VERA -0.21%

VERU 1.85%

VERV -0.11%

VIGL 4.81%

VINC 4.21%

VIR -3.57%

VIRI 2.46%

VIRX 6.31%

VKTX -5.39%

VLON -13.04%

VNDA -1.42%

VOR -4.39%

VRCA 3.74%

VRDN 6.22%

VRNA 0.87%

VRPX -0.14%

VRTX -0.18%

VSTM 4.90%

VTGN 1.36%

VTVT 0.50%

VTYX -7.11%

VXRT -5.32%

VYGR -0.46%

VYNE -1.08%

VYNT 7.78%

WINT -4.15%

WVE 2.54%

XBIO -0.26%

XBIT 1.52%

XCUR 4.09%

XENE -0.92%

XERS -1.51%

XFOR 1.92%

XLO 4.72%

XLRN 0.00%

XNCR -0.46%

XOMA 3.05%

XOMAO -0.25%

XOMAP 0.00%

XRTX -0.46%

YMAB -1.12%

ZGNX 0.00%

ZIOP -0.88%

ZLAB 0.15%

ZNTL -2.58%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Truex Samantha	Buy	0
2024-03-27	Goldman Jonathan	Buy	0
2024-03-28	Kantoff Aaron	Buy	0
2023-12-20	Persson Magnus	Buy	3 334	Stock Option (Right to Buy)
2023-12-20	Almenoff June Sherie	Buy	3 334	Stock Option (Right to Buy)

INSIDER POWER
-64.92
Last 97 transactions
Buy: 5 555 925 \| Sell: 5 291 542

Correlation (AI algo v.1.1b): Undervalued: 50 054 374.01% $5 562 504 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.17 (neutral)

Short: -0.12 (neutral)

Signal:(53.768) Neutral

Avalo Therapeutics, Inc. Correlation

10 Most Positive Correlations
RFAIU	0.931
BOTT	0.819

10 Most Negative Correlations
OZEM	-1
EIOMX	-0.917
KMDNX	-0.917
NICHX	-0.891
CCLFX	-0.869
AMCLX	-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avalo Therapeutics, Inc. Correlation - Currency/Commodity

-0.30
( neutral )

-0.37
( neutral )

0.00
( neutral )

-0.13
( neutral )

0.34
( neutral )

-0.56
( weak negative )

Avalo Therapeutics, Inc. Financials

Annual	2023
Revenue:	$1.92M
Gross Profit:	$640 000 (33.26 %)
EPS:	$-113.58

FY	2023
Revenue:	$1.92M
Gross Profit:	$640 000 (33.26 %)
EPS:	$-113.58

FY	2022
Revenue:	$18.05M
Gross Profit:	$14.62M (80.98 %)
EPS:	$-1 062.68

FY	2021
Revenue:	$5.40M
Gross Profit:	$3.91M (72.38 %)
EPS:	$-9.96

Financial Reports:

No articles found.

Avalo Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe Crohn\'s disease, and ulcerative colitis; and Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still\'s disease, including adult-onset still\'s disease and systemic juvenile idiopathic arthritis. Its products for rare genetic diseases in Phase III clinical trials include AVTX-801, a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency (PGM1), also known as PGM1-CDG; and AVTX-803, a L-fucose substrate replacement therapy for the treatment of LADII, also known as SLC35C1-CDG. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.